On March 22, the 16th International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo (CACLP Expo for short) opened at Jiangxi Nanchang Greenland International Expo Center. Shandong Orient Ocean Technology Co., Ltd. (hereinafter referred to as Orient Ocean Great Health) participated in the exhibition for the first time with its subsidiaries and their self-developed diagnostic reagent products and equipment. Once it appeared, it attracted the attention of industry experts and professional audiences. Hundreds of related companies and institutions in the IVD field were attracted on the day to understand and discuss cooperation matters.
Shortly after the opening of the Expo, Professor Song Haibo, Vice President of the National Health Industry Enterprise Management Association, President of the Medical Inspection Industry Branch of the National Health Industry Enterprise Management Association, and Secretary General of the Experimental Medicine Branch of the National Health Industry Enterprise Management Association; Doctor of Medicine, Second-level Professor, Doctoral Student Instructor, State Council Special Allowance Expert, Director of Shanghai Clinical Laboratory Center, Director of Laboratory Medicine Branch of National Health Industry Enterprise Management Association Professor Wang Hualiang; Director of Laboratory Department of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Chairman of Laboratory Physician Branch of Shanghai Medical Doctor Association Professor Shen Lisong and other well-known experts in the industry visited the booth of Oriental Ocean Health, and spoke highly of its self-developed reagent products and instruments.
Chairman Song Haibo (third from the right), Director Wang Hualiang (third from the left), and Director Shen Lisong (second from the right) visited the booth of Orient Ocean Healthcare, and met with Che Zhiyuan (first from the right), President of Orient Ocean Healthcare Business Unit, and Orient Ocean Healthcare Group photo of Professor Zhang Heqiu (second from left), chief engineer of the business unit and dean of Oriental Ocean (Beijing) Medical Research Institute, and Zhang Lei (first from left), vice president of Oriental Ocean Health Division
During this exhibition, Aveco Biotechnology Co., Ltd., Mass Spectrometry Biotechnology Co., Ltd., Oriental Ocean (Beijing) Medical Research Institute, Tenren Medical Laboratory and Yantai Yuangu Gene Technology Co., Ltd. Self-developed diagnostic reagents, instruments and equipment, product raw materials, testing service items, etc. will participate in the exhibition.
Among them, the series of detection reagents for newborn screening from Mass Spectrometry Biotechnology Co., Ltd. has attracted great attention from the industry. The basic newborn screening kits in this series of products can detect 50 kinds of inherited metabolic diseases at the same time, and its product advantages far exceed Other similar products in the market; vitamin D detection reagents, other in vitro diagnostic products and mass spectrometry related instruments and equipment also attracted many on-site visitors to stop and inquire.
The staff of Mass Spectrometry Biotechnology Co., Ltd. introduced mass spectrometry related products and equipment to customers
The self-developed pepsinogen Ⅰ, pepsinogen Ⅱ, gastrin 17 and other gastric function test kits (enzyme-linked immunosorbent assay, chemiluminescence method) exhibited by Aveco Biotechnology Co., Ltd. have been obtained. The "Medical Device Registration Certificate" has entered the market. On the day when the series of products were exhibited, they have reached further cooperation intentions with a number of distributors and agents.
The pepsinogen I, pepsinogen II,
Gastrin 17 and other gastric function series assay kits (enzyme-linked immunosorbent assay, chemiluminescence assay)
In addition, the raw materials and products used for the research and development of immunodiagnostic reagents displayed by the Oriental Ocean (Beijing) Medical Research Institute and the prospective systematic solutions for leukemia jointly launched by Tenren Medical Laboratory and Yantai Yuangu Gene Technology Co., Ltd. , has also become the focus of heated discussions among customers and clinical testing professionals in the field of immunodiagnosis.
Staff of Tenren Medical Laboratory and Yantai Yuangu Gene Technology Co., Ltd. introduced prospective and systematic solutions for leukemia
Attached is a list of all subsidiaries and their key products exhibited by Orient Ocean Health.